Literature DB >> 19539455

Hospitalisation days in patients with lung cancer in a general population.

Knut Skaug1, Geir Egil Eide, Amund Gulsvik.   

Abstract

BACKGROUND: Little is known concerning the hospitalisation of all lung cancer patients in a geographically defined population.
METHOD: All incident lung cancer patients in the Haugalandet area in South-west Norway from 1990 through 1996 were followed from diagnosis till either death or end of follow-up 1 December 2003. Initial symptoms, anatomical stage, functional performance status, histology, initial treatment, terminal care, number of admissions as well as days of hospitalisation were recorded.
RESULTS: Of a total of 271 patients (57 women) only 16 were still alive at end of follow-up. Median survival time was 170 days. Mean age at the first admission was 67.4 years (range 21-89 years). Median number (inter quartile range) of admissions was 3 (2, 5) and total hospitalisation days 35 (18, 58). Altogether 26% of the days in institutional care were spent in nursing homes. The 31 patients surgically treated had the highest number of hospitalisation days: 75 (56, 96). Young age, low anatomical stage and good performance status at time of diagnosis were associated with increased use of hospitalisation days. Cox regression analysis showed that treatment interventions and dyspnoea were significant predictors when adjusting for age, tumour stage and performance status.
CONCLUSION: In a population-based cohort of incident lung cancer patients, days in health care institutions involved a large part (19%) of all survival time for those who died. However, the absolute number was greater for those with small tumours and high functional performance status which initiated other interventions than palliative treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19539455     DOI: 10.1016/j.rmed.2009.05.016

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

Review 1.  Dyspnea review for the palliative care professional: assessment, burdens, and etiologies.

Authors:  Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy
Journal:  J Palliat Med       Date:  2011-09-06       Impact factor: 2.947

2.  Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review.

Authors:  Rezwanul Hasan Rana; Fariha Alam; Khorshed Alam; Jeff Gow
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-03       Impact factor: 4.553

3.  Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden.

Authors:  Kristof Cuppens; Christel Oyen; Aurélie Derweduwen; Anouck Ottevaere; Walter Sermeus; Johan Vansteenkiste
Journal:  Support Care Cancer       Date:  2016-01-27       Impact factor: 3.603

4.  Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.

Authors:  Alison Haywood; Jacqueline Duc; Phillip Good; Sohil Khan; Kirsty Rickett; Petra Vayne-Bossert; Janet R Hardy
Journal:  Cochrane Database Syst Rev       Date:  2019-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.